Table 2.
Sample ID |
Total no. of oligodendrocytes |
Percentage HHV-6 positive |
Age and sex |
Multiple sclerosis type and duration |
Post-mortem interval |
Days in fixation |
---|---|---|---|---|---|---|
MS 77 LES 1 | 188 (9/view) | 84% | F 57 | Multiple sclerosis 31 years | 28 h | 8 |
MS 77 LES 2 | 4358 (32/view) | 97% | F 57 | Multiple sclerosis 31 years | 28 h | 8 |
MS 80 LES | 1221 (24/view) | 23% | F 71 | Secondary progressive MS 35 years | 24 h | 12 |
MS 88 NAWM | 645 (17/view) | 50% | F 54 | Chronic multiple sclerosis 20 years | 22 h | 10 |
MS 88 LES | 1536 (29/view) | 77% | F 54 | Chronic multiple sclerosis 20 years | 22 h | 10 |
MS 97 NAWM | 1640 (29/view) | 24% | M 55 | Multiple sclerosis, details N/A | 31 h | 14 |
MS 97 LES | 3098 (58/view) | 10% | M 55 | Multiple sclerosis, details N/A | 31 h | 14 |
MS 102 NAWM | 3773 (47/view) | 7% | M 73 | PPMS 52 years | 20 h | 26 |
MS 102 LES | 6606 (43/view) | 19% | M 73 | PPMS 52 years | 20 h | 26 |
MS 103 NAWM | 1107 (26/view) | 27% | F 77 | PPMS 20 years | 7 h | 24 |
MS 103 LES | 3200 (53/view) | 7% | F 77 | PPMS 20 years | 7 h | 24 |
MS 107 LES 1 | 2750 (28/view) | 36% | M 38 | Progressive RMS 18 years | 19 h | 22 |
MS 107 LES 2 | 216 (14/view) | 56% | M 38 | Progressive RMS 18 years | 19 h | 22 |
Control 14 | 570 (10/view) | 12% | F 64 | COD = myocardial infarction | 18 h | 22 |
Control 15 | NA | 0% | M 82 | COD = schizophrenia | 21 h | 18 |
Control 16 | NA | 0% | M 92 | COD = cardiac failure | 13 h | 10 |
NA = not applicable; N/A = not available; PPMS = primary progressive multiple sclerosis; RMS = relapsing multiple sclerosis; COD = cause of death